The high dose adm inistration of the racemic folinic acid ([6/?S]-N5-form yltetrahydrofolic acid, C H O -TH FA ) combined with the antim etabolite 5-fluorouracil (5FU ) has been found to improve the tum oral response of 5F U in the treatm ent of colonadenocarcinom a [1, 2] or breast cancer [3] . The way of action of CH O -TH FA might be a "biom odulation" by forming a stable ternary co valent complex with 5F U and the active enzyme thymidilat synthetase [4] , The biochemical ration ale for this approach presumes, that high doses of folinic acid increase the cellular pools o f reduced folates [5] . Conversion o f C H O -TH FA to N 5,N ,0-methylenetetrahydrofolate (CH2-TH FA ) en hances the form ation and stability o f the ternary FdU M P -thymidilate synthetase -C H 2-TH FA complex, which in turn causes a profound inhibi tion of dTM P de novo synthesis and consequently results in impairm ent of D N A synthesis [6] [7] [8] .
C H O -TH FA has two chiral carbon centers; one chiral center is located on the 6-position in the pteridine ring portion and the other is in the ter minal glutam ate portion of the molecule (Fig. 1) . Thus, C H O -TH FA has four different optical iso mers. Commercially available CHO-TH FA , how ever, is a 1:1 mixture of [6/?]-and [6S]-isomers as only 1-glutam ate is used in the synthetic process.
The pharmacokinetic behaviour of the two iso mers differs in that the [6 S]-isomer is selectively absorbed from the gastroenteric tract and has a shorter half-life [8] In a previous in vivo study we found out that the racemic C H O -TH FA is bound from 12 to 40% to RBCs [9] ; however, as the therapeutically active form o f C H O -TH FA is the [6 5 ]-enantiom er, the purpose of the present study was to find out, whether there is a difference in the binding rate of [6 5 ]-and [6 /?]-CHO-THFA to RBCs or not.
Materials and Methods

Chem icals
All solvents were from H PLC grade purity (Merck, D arm stadt, Germany). 
R e d b lood cells pu rification
RBCs were obtained as a fresh "erythrocyte concentrate" from the surgical departm ent of the Hospital-Rudolf-Stiftung. The RBCs were washed with isotonic sodium chloride solution as de scribed [13, 14] , centrifuged for 5 min at 6000 rpm (Biofuge B, Haereus Christ, Vienna, Austria) and finally diluted with isotonic sodium chloride solu tion for a hem atocrit of 0.45. These solutions were used immediately for the experiments.
D rug solutions and binding experim en ts
CH O -TH FA was directly used from the m anu facturer's formulations, diluted with isotonic so dium chloride solution and pipetted into 1.0 ml of the fresh prepared RBC suspension to give final concentrations from 1.0 to 12.5 |ig/ml (for concen trations see Tables I and II) . The samples were vortexed for 1 min (Paramix II, Julabo, Seelbach, Germany) and kept in dark at 37 °C for 20 min (to avoid photodegradation of the drug). The suspen sion was centrifuged at 6000 rpm for 4 min (Bio fuge B, Haereus Christ, Vienna, Austria), the supernatant was filtered through a 20 jim filter (Millipore, Bedford, U.S.A.) and injected directly into the liquid chrom atograph w ithout further purification. F or each concentration the binding experiments were performed four times to obtain minimal statistical inform ation. As a control each set of experiments was performed with isotonic sodium chloride solution, too.
A n a lytica l procedu re Q uantitation o f [65]-and [6/?]-CHO-THFA was perform ed by high performance liquid chro m atography using a chiral BSA column as described [15] [16] [17] ,
B iom etric calculations
The red blood cell coefficient of partition (&RBC) was calculated as given in equation (1) The degradation half-life o f the com pounds was calculated by use o f the program "PC N onlin" on a PC AT 386 SX20, Anova analysis of variance was perform ed by use of the scientific package "Statist" on an Atari MegaST. Multiple iterative regression analysis o f CH O -TH FA concentrations versus cSN, cRBC and k KBC was perform ed on an Atari M egaST using the program W istat. Conver sion and plotting of the data in regard to binding sites was performed according a modified m ethod o f Scatchard [18] .
Results and Discussion
The bound am ounts of [65]-and [6 ^-C H O -T H F A at different concentrations are listed in the Tables I  and II , respectively, whereby a linear regression can be calculated between drug concentration and Cfree, £ rbc an^ % bound an<^ a parabolic regression between drug concentration and cbound. This phe nom enon could be observed for both, the Fig. 2 ). In the case of the [6 /?]-isomer the limit is reached at ~4 ng/ml of free drug. As the drug and RBC concentrations in the present in vitro study are equal for the observed in vivo am ounts, the percentual distribution of 2:1 [65] to [6/?] might be in a similar order of magni tude. c free
Fig. 2. Scatchard plot for [65]-( • ) and [6 ^-C H O -THFA (O).
In a second serie of experiments, the influence of RBCs on the degradation (bioconversion) of the two isomers was studied. In the observed time inter val o f 24 h (at 23 °C) we found a m onophasic degra dation mechanism under the influence o f RBCs and of NaCl solution. The mean half-lives were lower for both com pounds in the RBCs (Table III) .
This process seems to be o f a slow reaction, be cause in the first two hours after start o f the experi ments no difference could be observed between RBCs and sodium chloride solution.
The ratio of the two isomers is influenced by their degradation in the test solutions, but abso lutely no indices could be found for any conver sion of [6S] to [6/?] or vice versa, so the adm inis tration of the [65]-isomer will not lead to any loss of action caused by racemization.
The observed binding rates are in accordance with our results obtained from a preclinical trial com paring the binding rate of racemic CHO-T H F A to RBCs after i.v. and i.a. adm inistration [9] . In this study we found out that [6/?5]-CHO-T H F A is bound to RBCs in the concentration range from 2.7 to 5.2 |ig/ml (after i.v. bolus) at 12.0 to 27.8% (&RBC = 0.14 to 0.39) and from 2.1 to 4.3 |ig/ml (after i.a. bolus) at 12.3 to 45.7% (*RBC = 0.14 to 0.84).
The im portance of the RBCs for the folate pool is docum ented by the endogenous parent com pound folic acid, which is localized in the RBCs to more than 90% [19] .
The 
